Kalbe Farma Tbk Unsponsored ADR logo

Kalbe Farma Tbk Unsponsored ADR (PTKFY)

Market Closed
10 Aug, 20:00
OTC PINK OTC PINK
$
8. 78
+0.4
+4.7733%
$
9.95M Market Cap
21.7 P/E Ratio
0.51% Div Yield
900 Volume
0 Eps
$ 8.38
Previous Close
Add Transaction
Day Range
8.78 8.78
Year Range
7.63 18.59
Want to track PTKFY and more in your Portfolio? 🎯
Sign up for Marketlog, a portfolio tracker that will exceed your expectations!

Summary

PTKFY closed yesterday higher at $8.78, an increase of 4.7733% from Friday's close, completing a monthly decrease of -2.2272% or -$0.2. Over the past 12 months, PTKFY stock lost -45.4997%.
PTKFY pays dividends to its shareholders, with the most recent payment made on Jul 14, 2026. The next estimated payment will be in In 11 months on Jul 14, 2027 for a total of $0.224.
The last earnings report, released on Apr 28, 2026, exceeded the consensus estimates by 0%. On average, the company has surpassed earnings expectations by 4.8133%, based on the last three reports.
Kalbe Farma Tbk Unsponsored ADR has completed 1 stock splits, with the recent split occurring on Oct 25, 2012.
The company's stock is traded on one exchange.

PTKFY Chart

People also search for

Decker Manufacturing Corporation
$ 57.01
0%
Cannabix Technologies Inc.
$ 0.37
-3.0526%
VicapSys Life Sciences Inc.
$ 1.45
0%
Nuo Therapeutics Inc.
$ 0.85
0%
Quantumzyme Corp.
$ 0.8
+33.3333%

Kalbe Farma Tbk Unsponsored ADR (PTKFY) FAQ

What is the stock price today?

The current price is $8.78.

On which exchange is it traded?

Kalbe Farma Tbk Unsponsored ADR is listed on OTC PINK.

What is its stock symbol?

The ticker symbol is PTKFY.

Does it pay dividends? What is the current yield?

Yes, It pays dividends and the current yield is 0.51%.

What is its market cap?

As of today, the market cap is 9.95M.

Has Kalbe Farma Tbk Unsponsored ADR ever had a stock split?

Kalbe Farma Tbk Unsponsored ADR had 1 splits and the recent split was on Oct 25, 2012.

Kalbe Farma Tbk Unsponsored ADR Profile

Pharmaceuticals Industry
Healthcare Sector
Bernadette Ruth Setiady CEO
OTC PINK Exchange
69368A108 CUSIP
ID Country
12,835 Employees
5 Jun 2026 Last Dividend
25 Oct 2012 Last Split
- IPO Date

Overview

PT Kalbe Farma Tbk., founded in 1966 and headquartered in Jakarta, Indonesia, is a leading pharmaceutical company that engages in the development, manufacturing, and trading of pharmaceutical products. Operating through its various subsidiaries, the company serves a diversified market in Indonesia across four main divisions: Prescription Pharmaceuticals, Consumer Health, Nutritionals, and Distribution and Logistic. With a commitment to improving health outcomes, PT Kalbe Farma offers a broad range of products, from generic and branded drugs to nutritional supplements and medical equipment. Furthermore, the company extends its services to clinical study management, distribution of consumer goods, and healthcare services through Mitrasana Clinics.

Products and Services

  • Prescription Pharmaceuticals: Includes a diverse portfolio of generic, branded, and licensed drugs, such as Brainact, Cefspan, Mycoral, Cernevit, Cravit, Neuralgin, Broadced, Neurotam, Hemapo, and CPG, catering to various medical needs and distributed to hospitals, pharmacies, and drug stores.
  • Consumer Health: Offers over-the-counter drugs, targeting a range of common health issues and supporting everyday well-being.
  • Nutritionals: Provides nutritional products tailored for different age groups and health conditions, including infants, toddlers, children, teenagers, adults, pregnant and lactating women, and elders, as well as specialized medical needs. The range covers energy drinks, ready-to-drink products, supplements, and other preventive products.
  • Distribution and Logistic: Ensures efficient delivery and distribution of the company’s wide array of products, including consumer products, medical equipment, and cosmetics, among others.
  • Contract Services: Offers contract services to other pharmaceutical companies, which include clinical study management, bioavailability/bioequivalence studies, and contract analysis.
  • Animal Health Products: Develops and provides products designed for the health and wellness of animals, extending the company's health care reach beyond humans.
  • Healthcare Services: Through Mitrasana Clinics, the company delivers quality healthcare services, emphasizing preventive care and wellness.
  • Biotechnology Products: Acts as an agent and representative for a range of biotechnology products, enhancing its product portfolio with advanced scientific innovations.
  • Medical and Laboratory Equipment: Trades in a wide selection of medical and laboratory equipment and supplies, supporting the operational needs of healthcare providers.
  • Raw Materials for Pharmaceutical Products: Supplies raw materials necessary for the production of pharmaceutical goods, catering to the manufacturing sector of the industry.
  • Consumable Products for Hemodialysis Therapy: Provides essential consumable products used in hemodialysis therapy, contributing to the treatment of kidney diseases.
  • Advertising Services: Offers advertising services, likely aimed at promoting health and pharmaceutical products to a broader audience.

Contact Information

Address: Gedung KALBE
Phone: 62 21 4287 3888